Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05021679 · ClinicalTrials.gov registry record · NA
AMP Step Wedge Trial
A NA study, sponsored by Johns Hopkins University.
- Completed
- Registry status
- NA
- Development phase
- 16,676
- Enrollment target
NCT05021679: Completed NA study, sponsored by Johns Hopkins University.
NCT05021679 is a NA study that has completed, run by Johns Hopkins University. The registered enrollment target is 16,676 participants, above the 1,403-participant average among 58,714 other NA trials with a reported enrollment target (1089% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05021679, a NA study, has completed, sponsored by Johns Hopkins University.
- COMPLETED
- Registry status
- NA
- Development phase
- 16,676 participants
- Enrollment target
Study Summary
Annually, more than 35 million patients are hospitalized in the United States. Many of these will experience hospital-acquired loss of physical functioning due to a lack of mobility during their in-patient stay. Such loss includes difficulties performing basic activities, such as rising from a chair, toileting, or ambulating. This loss of function may increase hospital length of stay (LOS), nursing home placement, and decrease mobility and participation in community activities even years after hospitalization. Prevention of this hospital-acquired functional loss is critical. Even the sickest hospitalized patients (e.g., those in the intensive care unit \[ICU\]), can safely and feasibly benefit from early mobilization. In the non-ICU setting there is evidence that patient mobilization reduces LOS and hospital costs, while improving patient satisfaction and physical and psychological outcomes. The overall objective of this proposed project is to evaluate the implementation and impact of a transdisciplinary and multifaceted mobility program (Johns Hopkins Activity and Mobility Promotion - AMP) on clinical outcomes among hospitalized adults. In addition to clinical outcomes, we will identify barriers and facilitators to high-performance program adoption. Results of this project will provide critical new insights on the effectiveness of AMP and inform dissemination and implementation nationwide.
Primary Outcome
Mobility goal is set and measured using the Johns Hopkins Highest Level of Mobility (JH-HLM) Scale
Interventions
- OTHER AMP Implementation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16,676 participants |
| Start Date | 2021-01-01 |
| Est. Completion | 2024-04-01 |
| Phase | NA |
What the finished NCT05021679 record still lists
NCT05021679 is an interventional study that assigns participants to a tested intervention. Its 16,676 participants enrollment target places it among the larger protocols in the corpus, above the 1,403-participant average among 58,714 other NA trials with a reported enrollment target (1089% higher).
The record links to 0 conditions, and to 1 intervention - of which AMP Implementation is the first listed.
NCT05021679 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05021679 about?
NCT05021679 is a clinical study titled "AMP Step Wedge Trial". Annually, more than 35 million patients are hospitalized in the United States. Many of these will experience hospital-acquired loss of physical functioning due to a lack of mobility during their in-patient stay. Such loss includes difficulties performing basic activities, such as rising from a chair...
What is the current status of trial NCT05021679?
This trial is currently completed. It is a NA study. The enrollment target is 16,676 participants. The study started on 2021-01-01. Estimated completion is 2024-04-01.
What interventions are being tested in trial NCT05021679?
The interventions under investigation include: AMP Implementation (OTHER).
Who is sponsoring clinical trial NCT05021679?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05021679's enrollment target sits among peer trials
16,676 12th of 2000 higher than 1,989 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06951867 · 16,640 participants
Tezspire Cardiac Events PASS
- NCT06948838 · 16,895 participants · NA
Improving Hypertension Control in Safety-Net Settings: The Boston Hypertension Equity Alliance in Treatment
- NCT06479447 · 17,000 participants · NA
Patient Outcome Reporting for Timely Assessments of Life With Post-Traumatic Stress Disorder
- NCT06245187 · 17,198 participants
Get With the Guidelines Atrial Fibrillation Registry
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI